Martin Cullip is a former company director and International Fellow of the Taxpayers Protection Alliance, who has written and blogged on free market and lifestyle consumer issues for over a decade. As a user of e-cigarettes and other safer nicotine products, he is a particularly passionate consumer advocate for all forms of tobacco harm reduction and has a keen interest in the rapidly-evolving nicotine market and the politics surrounding it. Martin is a former Chair of UK educational charity, The New Nicotine Alliance, and has taken part in parliamentary evidence sessions and consumer, industry, and political events on the subject domestically and internationally.

Clive Bates has had a diverse career in the public, private and not-for-profit sectors. Starting out with IBM, he then switched career to work in the environment movement. From 1997-2003 he was Director of Action on Smoking and Health (UK), campaigning to reduce the harms caused by tobacco. In 2003 he joined Prime Minister Tony Blair’s Strategy Unit as a civil servant and worked in senior roles in the public sector and for the United Nations in Sudan. He is now Director of The Counterfactual, a consulting and advocacy practice focussed on a pragmatic approach to sustainability and public health.  

Fiona Patten is a Member for Northern Metropolitan Region in the Victorian Parliament’s Legislative Council. Leader of the Reason Party, Fiona was first elected in 2014 and re-elected in 2018. Since being elected in 2014, Fiona has garnered respect from all sides of the political divide and has worked tirelessly to deliver legislative reforms that many thought impossible. Fiona is now working towards improving Victoria even further, and is pushing to legalise and regulate cannabis for adult use, continuing to implement electoral reform, religious accountability and greater separation of church and state, legalise sex work, and spent convictions legislation.  

Joseph Magero is an avid tobacco harm reduction advocate. He has spent a decade working in tobacco control as the former director of the Africa Tobacco-Free Initiative, but after extensive research, consultation, and direct engagement with ex-smokers, scientists and tobacco harm reduction consumer advocates, he became convinced that giving smokers the option of switching to significantly safer (and enjoyable) nicotine products could provide a vital addition in reducing smoking related diseases. He is currently the chairman of Campaign For Safer Alternatives, a regional organisation that advocates for the adoption of tobacco harm reduction policies in Africa. His commitment to a smoke-free future remains undiminished.

Nancy Loucas is passionate about consumers having their voices heard in the narrative of THR and public health policy. Her consumer THR journey began in 2015 as one of the founders/co directors of Aotearoa Vapers Community Advocacy (AVCA) in New Zealand, doing battle for the rights of vapers to be able to access what they need to become/remain smoke free.

Nancy participated in developing INNCO from its inception (2016) and served as first president of the Governing Board in 2017-2018.

Nancy is currently the founder and Executive Coordinator for CAPHRA - the Coalition of Asia Pacific Tobacco Harm Reduction Advocates. CAPHRA supports consumer THR advocacy organisations and activities throughout the Asia Pacific region and has developed and presented various programmes for consumers such as the Voices4Vape online seminar series, the Right2Switch global consumer petition and, with CASAA in the US, the RightToVape.org Testimonial database that contains thousands of consumer testimonials globally.

Nancy is also the founder and director of Paraclete Associates Limited, (PAL), providing guidance on THR policy, regulation and programme development/advocacy mentoring globally. PAL was instrumental in the development and coordination of the sCOPe 5-day livestream that ran during the FCTC COP 9 in 2021. PAL also produces the consumer THR news show “The Advocates Voice.”

Harry Shapiro is Director of DrugWise – an online drug information service - and Managing Editor of DS Daily - the daily online drug, alcohol and tobacco news service. He has worked in the drugs field for over 40 years, first with the Institute for the Study of Drug Dependence and then from 2000 with DrugScope where he was Director of Communications until the charity folded in 2015.

Since 2015, he has been working with Knowledge-Action-Change promoting public health through harm reduction. He is the author and Executive Editor of the Global State of Tobacco Harm Reduction report, contributes a blog to Nicotine Science and Policy and is one of KAC’s media spokespeople.

Norbert is a software developer in Germany. Master in computer science (Dipl.-Inform.). He enjoyed smoking for 30+ years. Became an accidental quitter in 2012, when curiosity lead to experimenting with vaping. The growing variety of flavours was pivotal for enjoying vaping more than smoking. Later joined the German vaping consumers organization IG-ED. Now a member of the board and liaison to INNCO and ETHRA.

Professor Gerry Stimson is a leading advocate for tobacco harm reduction and an Emeritus Professor at Imperial College London. A public health social scientist, with over 50 years’ experience of research and advocacy, he was one of the founders of drugs harm reduction in the 1990s, helping to develop and evaluate harm reduction in the UK as a response to HIV/AIDS. Gerry has advised the UK Government, WHO, UNAIDS, UNODC, the World Bank and numerous governments around the world on issues relating to drugs, HIV infection and AIDS, and alcohol. He has also published over 220 scientific publications and several books. 

Currently, Gerry is Director of Research and Policy at Knowledge•Action•Change, and is involved in the FSFW-funded Global State of Tobacco Harm Reduction and Tobacco Harm Reduction Scholarship programmes. He is also a co-founder of the Global Forum on Nicotine, which has been delivered by KAC Communications since 2014. 

Professor Marewa Glover has worked on reducing smoking-related harm for over 25 years. She has worked as a policy analyst, a co-ordinator of a national tobacco control programme, cessation trainer and, for over 17 years, as a researcher. She has chaired numerous committees and organisations including End Smoking NZ, an independent NGO that lobbied for a harm reduction approach even before electronic cigarettes were introduced. Marewa has over 100 publications reflecting her leadership and support of numerous studies. Her primary focus has been reducing smoking during pregnancy and reducing smoking among Māori, the indigenous people of New Zealand. She has also been a co-investigator on a number of innovative cessation projects and a longitudinal online survey of New Zealand vapers. Dr Glover is the most prominent public commentator on vaping in NZ. She is regularly called by the media and has appeared on NZ’s 60 Minutes in addition to participating in live online and conference debates about vaping. Despite an initial ban on the import and sale of nicotine for vaping imposed by the Ministry of Health, vaping has become established as a common and successful way to reduce or stop smoking in NZ. Marewa, along with a small number of other researchers who early on foresaw the potential of ecigs, have helped make this happen.

Peter Hajek is Professor of Clinical Psychology and Director of the Tobacco Dependence Research Unit at the Wolfson Institute of Preventive Medicine, Queen Mary University of London. His research is concerned primarily with understanding health behaviours, and developing and evaluating both behavioural and pharmacological treatments for dependent smokers and for people with weight problems. Professor Hajek is a member of a number of expert groups, advisory bodies and editorial boards, and has authored or co-authored over 350 publications.

Helen Redmond is an expert in substance use with over a decade of experience working with drug users and people with mental health problems. Her current focus is on helping smokers from vulnerable groups switch to e-cigarettes. At New York Harm Reduction Educators, Helen facilitates tobacco harm reduction/vaping groups. She is a senior editor at Filter and writes about vaping and creates short Op-Docs. Helen is adjunct faculty at the Silver School of Social Work at New York University.

Will Godfrey is the founding editor-in-chief of Filter (https://filtermag.org), an online magazine that launched in 2018 to cover drug use, drug policy and human rights through a harm reduction lens. He's also the executive director of The Influence Foundation, the nonprofit behind Filter. He previously founded The Influence, an award-winning drug policy news site, and ran Substance.com and the addiction-focused site The Fix. Before that, he co-founded an award-winning print publication for incarcerated people in London. He has consulted for numerous organisations in the drug policy and harm reduction space. He lives in New York.

Nancy Loucas is passionate about consumers having their voices heard in the narrative of THR and public health policy. Her consumer THR journey began in 2015 as one of the founders/co directors of Aotearoa Vapers Community Advocacy (AVCA) in New Zealand, doing battle for the rights of vapers to be able to access what they need to become/remain smoke free.

Nancy participated in developing INNCO from its inception (2016) and served as first president of the Governing Board in 2017-2018.

Nancy is currently the founder and Executive Coordinator for CAPHRA - the Coalition of Asia Pacific Tobacco Harm Reduction Advocates. CAPHRA supports consumer THR advocacy organisations and activities throughout the Asia Pacific region and has developed and presented various programmes for consumers such as the Voices4Vape online seminar series, the Right2Switch global consumer petition and, with CASAA in the US, the RightToVape.org Testimonial database that contains thousands of consumer testimonials globally.

Nancy is also the founder and director of Paraclete Associates Limited, (PAL), providing guidance on THR policy, regulation and programme development/advocacy mentoring globally. PAL was instrumental in the development and coordination of the sCOPe 5-day livestream that ran during the FCTC COP 9 in 2021. PAL also produces the consumer THR news show “The Advocates Voice.”

Chim Ngoma is a passionate advocate for tobacco harm reduction and has led the THR Malawi project since 2018. He also works as an Assistant Manager on KAC’s THR Scholarship Programme. Chim has been involved in a number of notable THR projects and activities including the Burning Issues report and briefing paper on THR and the Right to Health as a reviewer. He also participated in a multi-stakeholder smoke-free dialogue in Cape Town aimed at informing the creation of the Smoke-Free Index, an initiative of the FSFW. Previously, Chim worked as a content writer consultant at Solimar International, as a citizen journalist at Nation Publications Limited and as a communications, visibility and M&E consultant at International Cooperation (GIZ).

Professor Marewa Glover has worked on reducing smoking-related harm for over 25 years. She has worked as a policy analyst, a co-ordinator of a national tobacco control programme, cessation trainer and, for over 17 years, as a researcher. She has chaired numerous committees and organisations including End Smoking NZ, an independent NGO that lobbied for a harm reduction approach even before electronic cigarettes were introduced. Marewa has over 100 publications reflecting her leadership and support of numerous studies. Her primary focus has been reducing smoking during pregnancy and reducing smoking among Māori, the indigenous people of New Zealand. She has also been a co-investigator on a number of innovative cessation projects and a longitudinal online survey of New Zealand vapers. Dr Glover is the most prominent public commentator on vaping in NZ. She is regularly called by the media and has appeared on NZ’s 60 Minutes in addition to participating in live online and conference debates about vaping. Despite an initial ban on the import and sale of nicotine for vaping imposed by the Ministry of Health, vaping has become established as a common and successful way to reduce or stop smoking in NZ. Marewa, along with a small number of other researchers who early on foresaw the potential of ecigs, have helped make this happen.

Konstantinos Farsalinos, MD, MPH is a physician and senior researcher at the University of Patras and the School of Public Health-University of West Attica in Greece. His field of expertise is Public Health. He has been conducting laboratory, clinical and epidemiological research on smoking, tobacco harm reduction and e-cigarettes as principal investigator since 2011. He authored the first systematic review on e-cigarette safety/risk profile, published in 2014. Additionally, he has performed research and published studies on heated tobacco products. His findings have been presented in major international scientific congresses and his studies were used in preparing the regulatory framework on e-cigarettes by the European Union. As of mid-2020, he has published more than 90 studies and articles in international peer-reviewed scientific journals about smoking, tobacco harm reduction and alternative-to-smoking nicotine products. He was the handling editor and author of a book titled "Analytical assessment of e-cigarettes", published by Elsevier in 2017. In November 2020, he was declared a Highly Cited Researcher 2019 by the Web of Science, a list of researchers (6200 scientists out of 9 million examined) with the highest impact in global science in 21 scientific fields in the past decade. During the COVID-19 pandemic, he has published 6 peer-reviewed studies and several pre-prints about the COVID-19, including the association between smoking, nicotine and COVID-19.

Dr Roberto A Sussman (PhD University of London) is a full time senior researcher and lecturer at the Institute for Nuclear Sciences of the National University of Mexico. His main research areas are General Relativity and Cosmology, but he has conducted research in other areas of Physics, including peer reviewed publications on e-cigarette aerosols. He is also the founder and Director of Pro-Vapeo Mexico, an association representing Mexican consumers of noncombustible nicotine products and is a member of INNCO. He is actively advocating for an appropriate regulation of Tobacco Harm Reduction products in Mexico. He directs and supervises the effort to spread scientific information on these products, as well as advising consumers on how to counter the gubernmental misinformation and prejudice about them that is rampant throughout Latin America.

David MacKintosh has over 20 years’ experience of working on alcohol and drug policy, this has included working within the UK Cabinet Office (UKADCU), heading up the London Drug and Alcohol Policy Forum (LDAPF) and providing specialist advice to the Greater London Authority. He also spent six years as Head of Community Safety for the City of London and has served as a trustee of a number of charities addressing substance use problems. He has helped deliver a range of innovative campaigns and national best practice guidance, which have all had one common purpose, to reduce harm to individuals and communities.  In 2020 he began working as an independent consultant and is now helping  Knowledge•Action•Change support and develop evidence based harm reduction programmes.

Clive Bates has had a diverse career in the public, private and not-for-profit sectors. Starting out with IBM, he then switched career to work in the environment movement. From 1997-2003 he was Director of Action on Smoking and Health (UK), campaigning to reduce the harms caused by tobacco. In 2003 he joined Prime Minister Tony Blair’s Strategy Unit as a civil servant and worked in senior roles in the public sector and for the United Nations in Sudan. He is now Director of The Counterfactual, a consulting and advocacy practice focussed on a pragmatic approach to sustainability and public health.  

Dr Roberto A Sussman (PhD University of London) is a full time senior researcher and lecturer at the Institute for Nuclear Sciences of the National University of Mexico. His main research areas are General Relativity and Cosmology, but he has conducted research in other areas of Physics, including peer reviewed publications on e-cigarette aerosols. He is also the founder and Director of Pro-Vapeo Mexico, an association representing Mexican consumers of noncombustible nicotine products and is a member of INNCO. He is actively advocating for an appropriate regulation of Tobacco Harm Reduction products in Mexico. He directs and supervises the effort to spread scientific information on these products, as well as advising consumers on how to counter the gubernmental misinformation and prejudice about them that is rampant throughout Latin America.

Professor Marewa Glover has worked on reducing smoking-related harm for over 25 years. She has worked as a policy analyst, a co-ordinator of a national tobacco control programme, cessation trainer and, for over 17 years, as a researcher. She has chaired numerous committees and organisations including End Smoking NZ, an independent NGO that lobbied for a harm reduction approach even before electronic cigarettes were introduced. Marewa has over 100 publications reflecting her leadership and support of numerous studies. Her primary focus has been reducing smoking during pregnancy and reducing smoking among Māori, the indigenous people of New Zealand. She has also been a co-investigator on a number of innovative cessation projects and a longitudinal online survey of New Zealand vapers. Dr Glover is the most prominent public commentator on vaping in NZ. She is regularly called by the media and has appeared on NZ’s 60 Minutes in addition to participating in live online and conference debates about vaping. Despite an initial ban on the import and sale of nicotine for vaping imposed by the Ministry of Health, vaping has become established as a common and successful way to reduce or stop smoking in NZ. Marewa, along with a small number of other researchers who early on foresaw the potential of ecigs, have helped make this happen.

Kevin McGirr is Clinical Professor in the School of Nursing; has taught in schools of medicine, social work and public health and was a Fulbright Scholar in Pondicherry India, 2013-2014.  He has over forty years experience in providing and managing behavioral health services; holds master’s degrees in public health, psychiatric nursing and ABD in public health. He has been involved in the training and development of harm reduction services and in particular utilizing Harm Reduction Tobacco interventions for persons with serious mental illness.

Riccardo Polosa is the Founder of the Center of Excellence for the acceleration of HArm Reduction (CoEHAR - University of Catania, Italy). Dr Polosa is Full Professor of Internal Medicine for the same University and Director of the Center for Smoking Prevention and Treatment at the University Hospital "Policlinico-V. Emanuele” of Catania. Dr. Polosa and the CoEHAR team of researchers conduct several high-profile clinical and behavioral research in the field of smoking-related diseases. According to a bibliometric analysis, Professor Polosa is considered the most productive scientist in the world in the field of electronic cigarette research.

Dr Brad Rodu is a professor of medicine and holds an endowed chair in tobacco harm reduction research at the University of Louisville, Kentucky USA. Since 1994 Rodu has authored 70 medical publications about tobacco, and he blogs at Rodu Tobacco Truth (http://rodutobaccotruth.blogspot.com/).

Professor Marewa Glover has worked on reducing smoking-related harm for over 25 years. She has worked as a policy analyst, a co-ordinator of a national tobacco control programme, cessation trainer and, for over 17 years, as a researcher. She has chaired numerous committees and organisations including End Smoking NZ, an independent NGO that lobbied for a harm reduction approach even before electronic cigarettes were introduced. Marewa has over 100 publications reflecting her leadership and support of numerous studies. Her primary focus has been reducing smoking during pregnancy and reducing smoking among Māori, the indigenous people of New Zealand. She has also been a co-investigator on a number of innovative cessation projects and a longitudinal online survey of New Zealand vapers. Dr Glover is the most prominent public commentator on vaping in NZ. She is regularly called by the media and has appeared on NZ’s 60 Minutes in addition to participating in live online and conference debates about vaping. Despite an initial ban on the import and sale of nicotine for vaping imposed by the Ministry of Health, vaping has become established as a common and successful way to reduce or stop smoking in NZ. Marewa, along with a small number of other researchers who early on foresaw the potential of ecigs, have helped make this happen.

Clive Bates has had a diverse career in the public, private and not-for-profit sectors. Starting out with IBM, he then switched career to work in the environment movement. From 1997-2003 he was Director of Action on Smoking and Health (UK), campaigning to reduce the harms caused by tobacco. In 2003 he joined Prime Minister Tony Blair’s Strategy Unit as a civil servant and worked in senior roles in the public sector and for the United Nations in Sudan. He is now Director of The Counterfactual, a consulting and advocacy practice focussed on a pragmatic approach to sustainability and public health.  

Fiona Patten is a Member for Northern Metropolitan Region in the Victorian Parliament’s Legislative Council. Leader of the Reason Party, Fiona was first elected in 2014 and re-elected in 2018. Since being elected in 2014, Fiona has garnered respect from all sides of the political divide and has worked tirelessly to deliver legislative reforms that many thought impossible. Fiona is now working towards improving Victoria even further, and is pushing to legalise and regulate cannabis for adult use, continuing to implement electoral reform, religious accountability and greater separation of church and state, legalise sex work, and spent convictions legislation.  

CECILIA KINDSTRAND-ISAKSSON, SWEDEN Cecilia Kindstrand is Director of Public Affairs for Swedish Match, a company with tobacco harm reduction at the core of its business. The company divested its cigarette business in 1999 and is now offering products that are recognized as safer alternatives to cigarettes. She is based in Brussels and has worked extensively with the EU regulatory matters, especially the TPD 2014/40 a legislation banning the ‘proof of concept’ of tobacco harm reduction in 26 of the 27 Member States.

Will Godfrey is the founding editor-in-chief of Filter (https://filtermag.org), an online magazine that launched in 2018 to cover drug use, drug policy and human rights through a harm reduction lens. He's also the executive director of The Influence Foundation, the nonprofit behind Filter. He previously founded The Influence, an award-winning drug policy news site, and ran Substance.com and the addiction-focused site The Fix. Before that, he co-founded an award-winning print publication for incarcerated people in London. He has consulted for numerous organisations in the drug policy and harm reduction space. He lives in New York.